1 completed, 1 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow Malignant Neoplasms of Digestive Organs: new trials by email Literature Review of Malignant Neoplasms of Digestive Organs trials Research Report on Malignant Neoplasms of Digestive Organs
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A LM-302 Combination With Other Anti-Tumor Therapies Phase ll Study LM-302, Toripalimab, Capecitabine - Malignant Neoplasms of Digestive Organs | Phase 2 | Recruiting | LaNova Medicines Zhejiang Co., Ltd. | 632 | 2023-07-27 | 2026-10-19 |
| Study of Durvalumab (MEDI4736) (Anti-PD-L1) and Trametinib (MEKi) in MSS Metastatic Colon Cancer Durvalumab, Trametinib - Malignant Neoplasms of Digestive Organs, Colorectal Cancer | Phase 2 | Completed | M.D. Anderson Cancer Center | 29 | 2018-03-21 | 2023-06-15 |
Colonic Neoplasms (1) · Colorectal Neoplasms (1)
Colonic Diseases (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Intestinal Diseases (1) · Intestinal Neoplasms (1) · Neoplasms (1) · Neoplasms by Site (1) · Rectal Diseases (1)
Capecitabine (1) · Gemcitabine (1) · Nivolumab (1) · Tegafur (1) · anlotinib (1) · apatinib (1) · durvalumab (1) · gimeracil (1) · potassium oxonate (1) · tislelizumab (1) · toripalimab (1) · trametinib (1)
LaNova Medicines Zhejiang Co., Ltd. (1) · M.D. Anderson Cancer Center (1)
China (1) · United States (1)
Aiping Zhou (1) · Chunmei Bai (1) · Deliang Fu (1) · Haijiao Yan (1) · Haiping Jiang (1) · Jieer Ying (1) · Jin Li (1) · Jing Dai (1) · Jun Zhou (1) · Kuirong Jiang (1) · Liang Liu (1) · Lixin Wan (1) · Michael Overman, MD (1) · Mingzhu Huang (1) · Ning Wu (1)